| scholarly article | Q13442814 |
| P2093 | author name string | Seung Joon Baek | |
| Michael F McEntee | |||
| Maria Cekanova | |||
| Seong-Ho Lee | |||
| P2860 | cites work | Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity | Q24649675 |
| The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter | Q24653488 | ||
| Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice | Q28368272 | ||
| Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis | Q28592219 | ||
| Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. | Q30727226 | ||
| 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase sign | Q30858775 | ||
| Gut-enriched Krüppel-like factor represses cyclin D1 promoter activity through Sp1 motif | Q33617171 | ||
| Increase of GKLF messenger RNA and protein expression during progression of breast cancer | Q33927101 | ||
| Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer | Q34290018 | ||
| Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression | Q34408251 | ||
| The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene | Q34462232 | ||
| Altered expression of the KLF4 in colorectal cancers | Q34543574 | ||
| PPAR dual agonists: are they opening Pandora's Box? | Q34618271 | ||
| Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells | Q35249254 | ||
| Gene alterations by peroxisome proliferator-activated receptor gamma agonists in human colorectal cancer cells | Q36825482 | ||
| Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways | Q37001526 | ||
| ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells | Q37098082 | ||
| KLF4-dependent, PPARgamma-induced expression of GPA33 in colon cancer cell lines. | Q37468620 | ||
| Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity. | Q38359904 | ||
| 2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells | Q40088710 | ||
| Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells | Q40130462 | ||
| 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit ovarian cancer cell growth through peroxisome proliferator-activated receptor-dependent and independent pathways | Q40286893 | ||
| Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC). | Q40479158 | ||
| RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells indu | Q40587179 | ||
| Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression | Q40884700 | ||
| Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. | Q42501465 | ||
| Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. | Q42507061 | ||
| Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. | Q43918569 | ||
| Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene | Q44002371 | ||
| Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells. | Q44342291 | ||
| Indole-3-carbinol and 3,3'-diindolylmethane induce expression of NAG-1 in a p53-independent manner | Q45238294 | ||
| Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer | Q57567933 | ||
| Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia | Q79353945 | ||
| Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach | Q81640280 | ||
| A novel peroxisome proliferator-activated receptor gamma ligand, MCC-555, induces apoptosis via posttranscriptional regulation of NAG-1 in colorectal cancer cells | Q83862119 | ||
| P433 | issue | 1-3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 30-37 | |
| P577 | publication date | 2010-04-10 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | MCC-555-induced NAG-1 expression is mediated in part by KLF4. | |
| P478 | volume | 637 |
| Q36238466 | A peroxisome proliferator-activated receptor ligand MCC-555 imparts anti-proliferative response in pancreatic cancer cells by PPARgamma-independent up-regulation of KLF4. |
| Q36497247 | CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling |
| Q55486841 | CRP Stimulates GDF15 Expression in Endothelial Cells through p53. |
| Q42768698 | Ethanol-induced changes in poly (ADP ribose) polymerase and neuronal developmental gene expression |
| Q55504431 | Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells. |
| Q34168476 | Nuclear receptors and pathogenesis of pancreatic cancer. |
| Q36596231 | Peroxisome proliferator-activated receptor γ agonists induce cell cycle arrest through transcriptional regulation of Kruppel-like factor 4 (KLF4) |
| Q38790569 | Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders |
Search more.